Skip to content
2000
Volume 25, Issue 4
  • ISSN: 1871-5265
  • E-ISSN: 2212-3989

Abstract

Background

Nasal colonization of increases the risk of nosocomial infections. Therefore, medications that can decolonize this pathogen can help prevent such infections.

Objective

Our study aimed to compare the efficacy of povidone-iodine solution with intranasal mupirocin ointment in decolonizing from the nasal cavity of healthcare workers.

Methods

This single-blinded randomized controlled trial was conducted on healthcare workers carrying nasally. After confirming nasal colonization through culture tests, participants were assigned to intervention groups A and B with an allocation ratio of 1:1. Group A received intranasal mupirocin ointment twice daily for five days, while group B received intranasal povidone-iodine solution twice daily for five days. After the decolonization period, samples were taken to compare the efficacy of both interventions in decolonizing .

Results

In this study, 54 healthcare workers with a mean age of 39.37±7.80 years were included, 42.6% and 57.4% of whom were male and female, respectively. They were randomly assigned to each of the intervention groups. After the intervention, individuals who received povidone-iodine had significantly more positive cultures than those who received mupirocin (37.0% 11.1%, = 0.026). Additionally, factors such as age, gender, wards, and employment duration may affect the efficacy of mupirocin and povidone-iodine in decolonizing from the nasal cavity.

Conclusion

The study findings revealed that both mupirocin and povidone-iodine were effective in decolonizing from nasal carriers. However, mupirocin was more effective compared with povidone-iodine.

Clinical Trial Registration Number

IRCT 20170417033487 N2.

Loading

Article metrics loading...

/content/journals/iddt/10.2174/0118715265301671240910070901
2024-09-20
2025-09-02
Loading full text...

Full text loading...

References

  1. RingbergH. Cathrine PeterssonA. WalderM. Hugo JohanssonP.J. The throat: An important site for MRSA colonization.Scand. J. Infect. Dis.2006381088889310.1080/00365540600740546 17008233
    [Google Scholar]
  2. BeigiR. HanrahanJ. Staphylococcus aureus and MRSA colonization rates among gravidas admitted to labor and delivery: A pilot study.Infect. Dis. Obstet. Gynecol.200720071410.1155/2007/70876 18273405
    [Google Scholar]
  3. LevyP.Y. OllivierM. DrancourtM. RaoultD. ArgensonJ.N. Relation between nasal carriage of Staphylococcus aureus and surgical site infection in orthopedic surgery: The role of nasal contamination. A systematic literature review and meta-analysis.Orthop. Traumatol. Surg. Res.201399664565110.1016/j.otsr.2013.03.030 23992764
    [Google Scholar]
  4. van RijenM. BontenM. WenzelR. KluytmansJ. Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers.Cochrane Libr.200820112CD00621610.1002/14651858.CD006216.pub2 18843708
    [Google Scholar]
  5. MehtaM.S. HacekD.M. KufnerB.A. PriceC. PetersonL.R. Dose-ranging study to assess the application of intranasal 2% mupirocin calcium ointment to eradicate Staphylococcus aureus nasal colonization.Surg. Infect.2013141697210.1089/sur.2012.086 23448592
    [Google Scholar]
  6. AmmerlaanH.S.M. KluytmansJ.A.J.W. WertheimH.F.L. NouwenJ.L. BontenM.J.M. Eradication of methicillin-resistant Staphylococcus aureus carriage: A systematic review.Clin. Infect. Dis.200948792293010.1086/597291 19231978
    [Google Scholar]
  7. KhoshnoodS. HeidaryM. AsadiA. A review on mechanism of action, resistance, synergism, and clinical implications of mupirocin against Staphylococcus aureus.Biomed. Pharmacother.20191091809181810.1016/j.biopha.2018.10.131 30551435
    [Google Scholar]
  8. YanoM. DokiY. InoueM. TsujinakaT. ShiozakiH. MondenM. Preoperative intranasal mupirocin ointment significantly reduces postoperative infection with Staphylococcus aureus in patients undergoing upper gastrointestinal surgery.Surg. Today2000301162110.1007/PL00010040 10648077
    [Google Scholar]
  9. CimochowskiG.E. HarostockM.D. BrownR. BernardiM. AlonzoN. CoyleK. Intranasal mupirocin reduces sternal wound infection after open heart surgery in diabetics and nondiabetics.Ann. Thorac. Surg.20017151572157910.1016/S0003‑4975(01)02519‑X 11383802
    [Google Scholar]
  10. PerlT.M. Prevention of Staphylococcus aureus infections among surgical patients: Beyond traditional perioperative prophylaxis.Surgery20031345Suppl.S10S1710.1016/S0039‑6060(03)00391‑X 14647028
    [Google Scholar]
  11. KonvalinkaA. ErrettL. FongI.W. Impact of treating Staphylococcus aureus nasal carriers on wound infections in cardiac surgery.J. Hosp. Infect.200664216216810.1016/j.jhin.2006.06.010 16930768
    [Google Scholar]
  12. PerlT.M. CullenJ.J. WenzelR.P. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections.N. Engl. J. Med.2002346241871187710.1056/NEJMoa003069 12063371
    [Google Scholar]
  13. SchmidH. RomanosA. SchifflH. LedererS.R. Persistent nasal methicillin-resistant Staphylococcus aureus carriage in hemodialysis outpatients: A predictor of worse outcome.BMC Nephrol.20131419310.1186/1471‑2369‑14‑93 23617360
    [Google Scholar]
  14. CaffreyA.R. WoodmanseeS.B. CrandallN. Low adherence to outpatient preoperative methicillin-resistant Staphylococcus aureus decolonization therapy.Infect. Control Hosp. Epidemiol.201132993093210.1086/661787 21828980
    [Google Scholar]
  15. MongkolrattanothaiK. MankinP. RajuV. GrayB. Surveillance for mupirocin resistance among methicillin-resistant Staphylococcus aureus clinical isolates.Infect. Control Hosp. Epidemiol.2008291099399410.1086/590536 18808349
    [Google Scholar]
  16. JonesJ.C. RogersT.J. BrookmeyerP. Mupirocin resistance in patients colonized with methicillin-resistant Staphylococcus aureus in a surgical intensive care unit.Clin. Infect. Dis.200745554154710.1086/520663 17682986
    [Google Scholar]
  17. SimorA.E. StuartT.L. LouieL. Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals.Antimicrob. Agents Chemother.200751113880388610.1128/AAC.00846‑07 17724154
    [Google Scholar]
  18. AndersonD.J. PodgornyK. Berríos-TorresS.I. Strategies to prevent surgical site infections in acute care hospitals: 2014 update.Infect. Control Hosp. Epidemiol.201435660562710.1086/676022 24799638
    [Google Scholar]
  19. McLureA.R. GordonJ. In-vitro evaluation of povidone-iodine and chlorhexidine against methicillin-resistant Staphylococcus aureus.J. Hosp. Infect.199221429129910.1016/0195‑6701(92)90139‑D 1355784
    [Google Scholar]
  20. Lanker KlossnerB. WidmerH.R. FreyF. Nondevelopment of resistance by bacteria during hospital use of povidone-iodine.Dermatology19971952101310.1159/000246024 9403249
    [Google Scholar]
  21. LepelletierD. MaillardJ.Y. PozzettoB. SimonA. Povidone iodine: Properties, mechanisms of action, and role in infection control and Staphylococcus aureus decolonization.Antimicrob. Agents Chemother.2020649e00682e2010.1128/AAC.00682‑20 32571829
    [Google Scholar]
  22. PhillipsM. RosenbergA. ShopsinB. Preventing surgical site infections: A randomized, open-label trial of nasal mupirocin ointment and nasal povidone-iodine solution.Infect. Control Hosp. Epidemiol.201435782683210.1086/676872 24915210
    [Google Scholar]
  23. MillasI. Duarte BarrosM. Estrogen receptors and their roles in the immune and respiratory systems.Anat. Rec.202130461185119310.1002/ar.24612 33856123
    [Google Scholar]
  24. KalmeijerM.D. CoertjensH. van Nieuwland-BollenP.M. Surgical site infections in orthopedic surgery: The effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study.Clin. Infect. Dis.200235435335810.1086/341025 12145715
    [Google Scholar]
  25. BaggeK. BenfieldT. WesthH. BartelsM.D. Eradicating MRSA carriage: The impact of throat carriage and Panton-Valentine leukocidin genes on success rates.Eur. J. Clin. Microbiol. Infect. Dis.201938468368810.1007/s10096‑019‑03474‑6 30684163
    [Google Scholar]
  26. RezapoorM. NicholsonT. TabatabaeeR.M. ChenA.F. MaltenfortM.G. ParviziJ. Povidone-iodine–based solutions for decolonization of nasal Staphylococcus aureus: A randomized, prospective, placebo-controlled study.J. Arthroplasty20173292815281910.1016/j.arth.2017.04.039 28578841
    [Google Scholar]
  27. GhaddaraH.A. KumarJ.A. CadnumJ.L. Ng-WongY.K. DonskeyC.J. Efficacy of a povidone iodine preparation in reducing nasal methicillin-resistant Staphylococcus aureus in colonized patients.Am. J. Infect. Control202048445645910.1016/j.ajic.2019.09.014 31735591
    [Google Scholar]
  28. TorresE.G. Lindmair-SnellJ.M. LanganJ.W. BurnikelB.G. Is preoperative nasal povidone-iodine as efficient and cost-effective as standard methicillin-resistant Staphylococcus aureus screening protocol in total joint arthroplasty?J. Arthroplasty201631121521810.1016/j.arth.2015.09.030 26521129
    [Google Scholar]
  29. MasanoH. FukuchiK. WakutaR. TanakaY. Efficacy of intranasal application of povidone-iodine cream in eradicating nasal methicillin-resistant Staphylococcus aureus in neonatal intensive care unit (NICU) staff.Postgrad. Med. J.199369Suppl. 3S122S125 8290448
    [Google Scholar]
/content/journals/iddt/10.2174/0118715265301671240910070901
Loading
/content/journals/iddt/10.2174/0118715265301671240910070901
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test